GlassScriptPhysician profile
Logan M Petit
NPI 1174052682
$25,809.38
in general payments reported to CMS, 2019-2025
12 companies · $188 in 2025
The $188 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $6,161 · 2023: $11K · 2024: $8,900 · 2025: $188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,690 · Consulting Fee: $5,500 · Travel and Lodging: $4,947 · Food and Beverage: $2,012 · Honoraria: $1,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,689.50 |
| Consulting Fee | $5,500.00 |
| Travel and Lodging | $4,946.81 |
| Food and Beverage | $2,011.84 |
| Honoraria | $1,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $11,587.49 | 2022-2024 | Acufex, Acufex Pinpoint, Bone Anchors With Arthroscopic Delivery System |
| Vericel Corporation | $5,622.76 | 2022-2024 | Maci |
| Encore Medical, LP | $3,105.92 | 2022-2023 | Djo Surgical |
| Arthrex, INC. | $2,831.39 | 2023-2024 | |
| Polaris Technology Solutions LLC | $1,422.44 | 2023-2025 | |
| Depuy Synthes Sales INC. | $689.86 | 2023-2025 | Inhance, Monovisc, Orthovisc |
| Zimmer Biomet Holdings, INC. | $175.72 | 2023-2024 | Comprehensive Shoulder System |
| Stryker Corporation | $165.81 | 2022-2025 | Pangea |
| Medical Device Business Services, INC. | $120.00 | 2024 | Inhance |
| Ferring Pharmaceuticals INC. | $38.43 | 2024-2025 | Euflexxa |
| Bioventus LLC | $26.46 | 2025 | Durolane |
| Pacira Pharmaceuticals Incorporated | $23.10 | 2025 | Iovera, Zilretta, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Petit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.